Table 3.
Adverse effects.
Adverse effect | Ipilimumab/RT | Ipilimumab alone | p-value |
---|---|---|---|
N | 70 | 31 | |
Colitis | 8 (11.4) | 1 (3.2) | 0.27 |
Hypophysitis | 2 (2.8) | 2 (6.4) | 0.58 |
Dermatitis | 3 (4.2) | 1 (3.2) | 1.00 |
Vitiligo | 2 (2.8) | 1 (3.2) | 1.00 |
LowACTH | 3 (4.2) | 3 (9.6) | 0.37 |
Low TSH | 1 (1.4) | 2 (6.4) | 0.23 |
Hepatitis | 1 (1.4) | 0 (0) | — |
Adrenalitis | 1 (1.4) | 0 (0) | — |
Pernicious anemia | 0 (0) | 1 (3.2) | — |
Adverse effects: Various toxicities are compared between the Ipi/RT and ipilimumab alone group to show that there was not a significantly greater risk of toxicity from the added radiotherapy in the Ipi/RT group. Values are presented as n (%) or as medians.
represents p < 0.05.